Free Trial
NASDAQ:MEDS

TRxADE HEALTH (MEDS) Stock Price, News & Analysis

TRxADE HEALTH logo
$1.03 -0.01 (-0.96%)
As of 08/27/2025

About TRxADE HEALTH Stock (NASDAQ:MEDS)

Key Stats

Today's Range
$1.02
$1.08
50-Day Range
$0.90
$2.39
52-Week Range
$3.69
$44.56
Volume
116,686 shs
Average Volume
207,831 shs
Market Capitalization
$1.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MEDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MEDS Stock News Headlines

TRxADE HEALTH (NASDAQ:MEDS) Shares Down 2.5% - Here's Why
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel
TRxADE Health (NASDAQ: MEDS)
Scienture Holdings, Inc. (SCNX)
See More Headlines

MEDS Stock Analysis - Frequently Asked Questions

TRxADE HEALTH's stock was trading at $6.20 at the start of the year. Since then, MEDS stock has decreased by 83.4% and is now trading at $1.03.

TRxADE HEALTH, Inc. (NASDAQ:MEDS) announced its earnings results on Sunday, October, 24th. The company reported ($2.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.95) by $0.45. The company earned $2.55 million during the quarter, compared to analysts' expectations of $1.94 million. TRxADE HEALTH had a negative trailing twelve-month return on equity of 196.79% and a negative net margin of 149.81%.

TRxADE HEALTH shares reverse split on the morning of Thursday, June 22nd 2023.The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TRxADE HEALTH investors own include NVIDIA (NVDA), Communications Systems (JCS), Biora Therapeutics (BIOR), Paratek Pharmaceuticals (PRTK), Citius Pharmaceuticals (CTXR), Meta Platforms (META) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
10/24/2021
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Wholesale
Current Symbol
NASDAQ:MEDS
CIK
1382574
Employees
50
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.84 million
Net Margins
-149.81%
Pretax Margin
-250.53%
Return on Equity
-196.79%
Return on Assets
-112.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.18
Quick Ratio
4.18

Sales & Book Value

Annual Sales
$7.45 million
Price / Sales
0.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
2.29

Miscellaneous

Outstanding Shares
1,406,000
Free Float
725,000
Market Cap
$1.45 million
Optionable
Not Optionable
Beta
2.32

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:MEDS) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners